Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.
Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, Lecouturier J, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. Among authors: pearce i. BMJ. 2022 Mar 9;376:e068229. doi: 10.1136/bmj-2021-0068229. BMJ. 2022. PMID: 35264408 Free PMC article. Clinical Trial.
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. Among authors: pearce i. Health Technol Assess. 2022 May;26(23):1-172. doi: 10.3310/QOIZ6538. Health Technol Assess. 2022. PMID: 35535708 Free article. Clinical Trial.
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial.
Forbes R, Ali A, Abouhajar A, Brennand C, Brown H, Carnell S, Chadwick T, Eardley I, Lecouturier J, Mossop H, Pearce I, Pickard R, Thiruchelvam N, Walton K, Wilkinson J, Harding C. Forbes R, et al. Among authors: pearce i. Trials. 2018 Nov 9;19(1):616. doi: 10.1186/s13063-018-2998-4. Trials. 2018. PMID: 30413181 Free PMC article.
Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic.
Gao C, Peters M, Kurver P, Anbarasan T, Jayaraajan K, Manning T, Cashman S, Nambiar A, Cumberbatch M, Lamb BW, Pickard R, Erotocritou P, Smith D, Kasivisvanathan V, Shah TT; BURST Collaborative MIMIC Study Group. Gao C, et al. BJU Int. 2022 Jun 28;130(6):823-31. doi: 10.1111/bju.15839. Online ahead of print. BJU Int. 2022. PMID: 35762278 Free PMC article.
LEARN: A multi-centre, cross-sectional evaluation of Urology teaching in UK medical schools.
Ng A, Wai-Shun Chan V, Asif A, Light A, Meng Lam C, Jayaraajan K, Cambridge WA, Gillian Matthews M, Kulkarni M, Zhi Yang Ooi S, Nathan A, Ahmed N, Gadhia S, Morka N, Hinchcliffe Z, Chen W, Young Yoon W, Das K, Kufuor RA, Patel K, Ayres B, Dacre J, Harding C, Page T, Pearce I, Bhatt NR, Khadhouri S, Kasivisvanathan V; LEARN Study Group Collaborators. Ng A, et al. Among authors: pearce i. BJU Int. 2022 Apr 29;130(5):676-87. doi: 10.1111/bju.15758. Online ahead of print. BJU Int. 2022. PMID: 35488402 Free PMC article.
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial.
Lois N, Burr J, Norrie J, Vale L, Cook J, McDonald A, Boachie C, Ternent L, McPherson G; Full-thickness Macular Hole and Internal Limiting Membrane Peeling Study (FILMS) Group. Lois N, et al. Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1586-92. doi: 10.1167/iovs.10-6287. Invest Ophthalmol Vis Sci. 2011. PMID: 21051731 Clinical Trial.
Dexamethasone implant for non-infectious uveitis: is it cost-effective?
Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I, Quhill FM. Squires H, et al. Among authors: pearce i. Br J Ophthalmol. 2019 Nov;103(11):1639-1644. doi: 10.1136/bjophthalmol-2018-312765. Epub 2019 Feb 11. Br J Ophthalmol. 2019. PMID: 30745307 Free article.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
194 results